1. Li, Ruth Zhen, Hou, Jing, Wei, Yaxun, Ye, Yali, Zhang, Yi. 2018. hnRNPDL extensively regulates transcription and alternative splicing. In Gene, 687, 125-134. doi:10.1016/j.gene.2018.11.026. https://pubmed.ncbi.nlm.nih.gov/30447347/
2. Fischer, Sandra, Lichtenthaeler, Chiara, Stepanenko, Anastasiya, Zarnack, Kathi, Weigand, Julia E. 2023. Heterogenous nuclear ribonucleoprotein D-like controls endothelial cell functions. In Biological chemistry, 405, 229-239. doi:10.1515/hsz-2023-0254. https://pubmed.ncbi.nlm.nih.gov/37942876/
3. Berardo, Andrés, Lornage, Xavière, Johari, Mridul, Romero, Norma Beatriz, Taratuto, Ana Lia. 2019. HNRNPDL-related muscular dystrophy: expanding the clinical, morphological and MRI phenotypes. In Journal of neurology, 266, 2524-2534. doi:10.1007/s00415-019-09437-3. https://pubmed.ncbi.nlm.nih.gov/31267206/
4. Batlle, Cristina, Yang, Peiguo, Coughlin, Maura, Taylor, J Paul, Ventura, Salvador. . hnRNPDL Phase Separation Is Regulated by Alternative Splicing and Disease-Causing Mutations Accelerate Its Aggregation. In Cell reports, 30, 1117-1128.e5. doi:10.1016/j.celrep.2019.12.080. https://pubmed.ncbi.nlm.nih.gov/31995753/
5. Song, Wei, Zhang, Houliang, Ni, Jinliang, Wang, Keyi, Peng, Bo. 2024. ALKBH5 promotes malignant proliferation of renal clear cell carcinoma by activating the MAPK pathway through binding to HNRNPDL. In International immunopharmacology, 145, 113776. doi:10.1016/j.intimp.2024.113776. https://pubmed.ncbi.nlm.nih.gov/39657539/
智鼠故事 
